| Year |
Citation |
Score |
| 2021 |
Oladejo M, Paterson Y, Wood LM. Clinical Experience and Recent Advances in the Development of -Based Tumor Immunotherapies. Frontiers in Immunology. 12: 642316. PMID 33936058 DOI: 10.3389/fimmu.2021.642316 |
0.36 |
|
| 2020 |
Ghouse SM, Vadrevu SK, Manne S, Reese B, Patel J, Patel B, Silwal A, Lodhi N, Paterson Y, Srivastava SK, Karbowniczek M, Markiewski MM. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis. Journal of Immunology (Baltimore, Md. : 1950). PMID 31900334 DOI: 10.4049/Jimmunol.1901208 |
0.346 |
|
| 2017 |
Markiewski MM, Vadrevu SK, Sharma SK, Chintala NK, Ghouse S, Cho JH, Fairlie DP, Paterson Y, Astrinidis A, Karbowniczek M. The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1. Journal of Immunology (Baltimore, Md. : 1950). PMID 28228558 DOI: 10.4049/Jimmunol.1602057 |
0.439 |
|
| 2016 |
Hernández-Flores KG, Calderón-Garcidueñas AL, Mellado-Sánchez G, Ruiz-Ramos R, Sánchez-Vargas LA, Thomas-Dupont P, Izaguirre-Hernández IY, Téllez-Sosa J, Martínez-Barnetche J, Wood L, Paterson Y, Cedillo-Barrón L, López-Franco O, Vivanco-Cid H. Evaluation of the safety and adjuvant effect of a detoxified Listeriolysin O mutant on the humoral response to Dengue virus antigens. Clinical and Experimental Immunology. PMID 27886660 DOI: 10.1111/cei.12906 |
0.335 |
|
| 2016 |
Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, ... ... Paterson Y, et al. A One Health overview, facilitating advances in comparative medicine and translational research. Clinical and Translational Medicine. 5: 26. PMID 27558513 DOI: 10.1186/S40169-016-0107-4 |
0.317 |
|
| 2016 |
Mason N, Gnanandarajah J, Engiles J, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y. Immunotherapy with a HER2 targeted Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26994144 DOI: 10.1158/1078-0432.Ccr-16-0088 |
0.421 |
|
| 2015 |
Bui CT, Shollenberger LM, Paterson Y, Harn DA. Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope. Clinical and Vaccine Immunology : Cvi. 22: 193-9. PMID 25520148 DOI: 10.1128/Cvi.00514-14 |
0.424 |
|
| 2015 |
Mason N, Gnanandarajah J, Laughlin D, Engiles J, Wallecha A, Paterson Y. Abstract LB-113: Recombinant HER2/Neu expressing Listeria combined with radiation safely delays tumor progression and prolongs overall survival in a phase I clinical study in canine osteosarcoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-113 |
0.349 |
|
| 2014 |
Bui CT, Shollenberger LM, Paterson Y, Harn DA. Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells. Clinical and Vaccine Immunology : Cvi. 21: 1232-9. PMID 24990901 DOI: 10.1128/Cvi.00138-14 |
0.447 |
|
| 2014 |
Wood LM, Paterson Y. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. Frontiers in Cellular and Infection Microbiology. 4: 51. PMID 24860789 DOI: 10.3389/Fcimb.2014.00051 |
0.516 |
|
| 2013 |
Shollenberger LM, Bui CT, Paterson Y, Nyhoff L, Harn DA. HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni. Vaccine. 31: 5651-8. PMID 24120546 DOI: 10.1016/J.Vaccine.2013.09.067 |
0.423 |
|
| 2013 |
Guirnalda P, Wood L, Goenka R, Crespo J, Paterson Y. Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes. Oncoimmunology. 2: e25752. PMID 24083082 DOI: 10.4161/Onci.25752 |
0.516 |
|
| 2013 |
Rothman J, Paterson Y. Live-attenuated Listeria-based immunotherapy. Expert Review of Vaccines. 12: 493-504. PMID 23659298 DOI: 10.1586/Erv.13.34 |
0.402 |
|
| 2013 |
Shollenberger LM, Bui C, Paterson Y, Allen K, Harn D. Successful vaccination of immune suppressed recipients using Listeria vector HIV-1 vaccines in helminth infected mice. Vaccine. 31: 2050-6. PMID 23470236 DOI: 10.1016/J.Vaccine.2013.02.037 |
0.406 |
|
| 2013 |
Wallecha A, Wood L, Pan ZK, Maciag PC, Shahabi V, Paterson Y. Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability. Clinical and Vaccine Immunology : Cvi. 20: 77-84. PMID 23136118 DOI: 10.1128/Cvi.00488-12 |
0.462 |
|
| 2012 |
Guirnalda PD, Paterson Y. Vaccination with immunotherapeutic Listeria monocytogenes induces IL-17(+) γδ T cells in a murine model for HPV associated cancer. Oncoimmunology. 1: 822-828. PMID 23162749 DOI: 10.4161/Onci.20491 |
0.45 |
|
| 2012 |
Guirnalda P, Wood L, Paterson Y. Listeria monocytogenes and its products as agents for cancer immunotherapy. Advances in Immunology. 113: 81-118. PMID 22244580 DOI: 10.1016/B978-0-12-394590-7.00004-X |
0.496 |
|
| 2012 |
Wood LM, Pan ZK, Seavey MM, Muthukumaran G, Paterson Y. The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. 61: 689-700. PMID 22057675 DOI: 10.1007/S00262-011-1129-9 |
0.456 |
|
| 2011 |
Lasaro MO, Sazanovich M, Giles-Davis W, Mrass P, Bunte RM, Sewell DA, Hussain SF, Fu YX, Weninger W, Paterson Y, Ertl HC. Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1727-36. PMID 21587210 DOI: 10.1038/Mt.2011.88 |
0.55 |
|
| 2011 |
Wood LM, Pan ZK, Guirnalda P, Tsai P, Seavey M, Paterson Y. Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. Cancer Immunology, Immunotherapy : Cii. 60: 931-42. PMID 21431419 DOI: 10.1007/S00262-011-1002-X |
0.496 |
|
| 2010 |
Paterson Y, Guirnalda PD, Wood LM. Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy. Seminars in Immunology. 22: 183-9. PMID 20299242 DOI: 10.1016/J.Smim.2010.02.002 |
0.494 |
|
| 2010 |
Wood LM, Pan ZK, Shahabi V, Paterson Y. Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy. Cancer Immunology, Immunotherapy : Cii. 59: 1049-58. PMID 20213121 DOI: 10.1007/S00262-010-0830-4 |
0.471 |
|
| 2010 |
Gravekamp C, Paterson Y. Harnessing Listeria monocytogenes to target tumors. Cancer Biology & Therapy. 9: 257-65. PMID 20139702 DOI: 10.4161/Cbt.9.4.11216 |
0.499 |
|
| 2009 |
Kim SH, Castro F, Paterson Y, Gravekamp C. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Research. 69: 5860-6. PMID 19584282 DOI: 10.1158/0008-5472.Can-08-4855 |
0.534 |
|
| 2009 |
Cooper HM, Paterson Y. Production of polyclonal antisera. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 5.5. PMID 19575471 DOI: 10.1002/0471143030.Cb1602S03 |
0.332 |
|
| 2009 |
Mustafa W, Maciag PC, Pan ZK, Weaver JR, Xiao Y, Isaacs SN, Paterson Y. Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization. Viral Immunology. 22: 195-204. PMID 19435416 DOI: 10.1089/Vim.2008.0071 |
0.398 |
|
| 2009 |
Seavey MM, Maciag PC, Al-Rawi N, Sewell D, Paterson Y. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model. Journal of Immunology (Baltimore, Md. : 1950). 182: 5537-46. PMID 19380802 DOI: 10.4049/Jimmunol.0803742 |
0.432 |
|
| 2009 |
Wallecha A, Carroll KD, Maciag PC, Rivera S, Shahabi V, Paterson Y. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics. Advances in Applied Microbiology. 66: 1-27. PMID 19203646 DOI: 10.1016/S0065-2164(08)00801-0 |
0.477 |
|
| 2009 |
Seavey MM, Pan ZK, Maciag PC, Wallecha A, Rivera S, Paterson Y, Shahabi V. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 924-32. PMID 19188163 DOI: 10.1158/1078-0432.Ccr-08-2283 |
0.409 |
|
| 2009 |
Wallecha A, Maciag PC, Rivera S, Paterson Y, Shahabi V. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy. Clinical and Vaccine Immunology : Cvi. 16: 96-103. PMID 19020110 DOI: 10.1128/Cvi.00274-08 |
0.442 |
|
| 2008 |
Wood LM, Guirnalda PD, Seavey MM, Paterson Y. Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunologic Research. 42: 233-45. PMID 19018479 DOI: 10.1007/S12026-008-8087-0 |
0.453 |
|
| 2008 |
Maciag PC, Seavey MM, Pan ZK, Ferrone S, Paterson Y. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Research. 68: 8066-75. PMID 18829565 DOI: 10.1158/0008-5472.Can-08-0287 |
0.536 |
|
| 2008 |
Cooper HM, Paterson Y. Production of polyclonal antisera. Current Protocols in Cytometry / Editorial Board, J. Paul Robinson, Managing Editor ... [Et Al.]. Appendix 3I. PMID 18770642 DOI: 10.1002/0471142956.Cya03Is43 |
0.332 |
|
| 2008 |
Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. British Journal of Cancer. 99: 741-9. PMID 18728665 DOI: 10.1038/Sj.Bjc.6604526 |
0.414 |
|
| 2008 |
Sewell DA, Pan ZK, Paterson Y. Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors. Vaccine. 26: 5315-20. PMID 18680778 DOI: 10.1016/J.Vaccine.2008.07.036 |
0.509 |
|
| 2008 |
Shahabi V, Reyes-Reyes M, Wallecha A, Rivera S, Paterson Y, Maciag P. Development of a Listeria monocytogenes based vaccine against prostate cancer. Cancer Immunology, Immunotherapy : Cii. 57: 1301-13. PMID 18273616 DOI: 10.1007/S00262-008-0463-Z |
0.497 |
|
| 2008 |
Cooper HM, Paterson Y. Production of polyclonal antisera. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 11.12. PMID 18231979 DOI: 10.1002/0471142727.Mb1112S81 |
0.332 |
|
| 2008 |
Neeson P, Pan ZK, Paterson Y. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. Cancer Immunology, Immunotherapy : Cii. 57: 493-505. PMID 17876582 DOI: 10.1007/S00262-007-0388-Y |
0.47 |
|
| 2007 |
Singh R, Paterson Y. Immunoediting sculpts tumor epitopes during immunotherapy. Cancer Research. 67: 1887-92. PMID 17332314 DOI: 10.1158/0008-5472.Can-06-3960 |
0.642 |
|
| 2007 |
Souders NC, Sewell DA, Pan ZK, Hussain SF, Rodriguez A, Wallecha A, Paterson Y. Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer. Cancer Immunity. 7: 2. PMID 17279610 |
0.788 |
|
| 2007 |
Singh R, Paterson Y. In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines. Cancer Immunology, Immunotherapy : Cii. 56: 927-38. PMID 17131121 DOI: 10.1007/S00262-006-0237-4 |
0.657 |
|
| 2007 |
Peng X, Treml J, Paterson Y. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. Cancer Immunology, Immunotherapy : Cii. 56: 797-806. PMID 17102978 DOI: 10.1007/S00262-006-0240-9 |
0.478 |
|
| 2007 |
Souders NC, Verch T, Paterson Y. Immunotherapeutic Strategies against Cancer using Listeria monocytogenes as a Vector for Tumor Antigens Cancer Vaccines and Tumor Immunity. 113-129. DOI: 10.1002/9780470170113.ch8 |
0.767 |
|
| 2006 |
Singh R, Paterson Y. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy. Expert Review of Vaccines. 5: 541-52. PMID 16989634 DOI: 10.1586/14760584.5.4.541 |
0.671 |
|
| 2006 |
Neeson P, Paterson Y. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Immunological Investigations. 35: 359-94. PMID 16916758 DOI: 10.1080/08820130600755009 |
0.489 |
|
| 2006 |
Neeson P, Boyer J, Kumar S, Lewis MG, Mattias L, Veazey R, Weiner D, Paterson Y. A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype. Virology. 354: 299-315. PMID 16904153 DOI: 10.1016/J.Virol.2006.06.036 |
0.373 |
|
| 2006 |
Singh R, Paterson Y. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer. Cancer Research. 66: 7748-57. PMID 16885378 DOI: 10.1158/0008-5472.Can-05-4469 |
0.644 |
|
| 2006 |
Souders NC, Verch T, Paterson Y. In vivo bactofection: listeria can function as a DNA-cancer vaccine. Dna and Cell Biology. 25: 142-51. PMID 16569193 DOI: 10.1089/Dna.2006.25.142 |
0.797 |
|
| 2006 |
Boyer JD, Maciag PC, Parkinson R, Wu L, Lewis MG, Weiner DB, Paterson Y. Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239. Vaccine. 24: 4498-502. PMID 16185790 DOI: 10.1016/J.Vaccine.2005.08.016 |
0.457 |
|
| 2005 |
Paterson Y, Maciag PC. Listeria-based vaccines for cancer treatment. Current Opinion in Molecular Therapeutics. 7: 454-60. PMID 16248280 |
0.425 |
|
| 2005 |
Singh R, Dominiecki ME, Jaffee EM, Paterson Y. Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. Journal of Immunology (Baltimore, Md. : 1950). 175: 3663-73. PMID 16148111 DOI: 10.4049/Jimmunol.175.6.3663 |
0.665 |
|
| 2005 |
Dominiecki ME, Beatty GL, Pan ZK, Neeson P, Paterson Y. Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors. Cancer Immunology, Immunotherapy : Cii. 54: 477-88. PMID 15750832 DOI: 10.1007/S00262-004-0610-0 |
0.43 |
|
| 2005 |
Boyer JD, Robinson TM, Maciag PC, Peng X, Johnson RS, Pavlakis G, Lewis MG, Shen A, Siliciano R, Brown CR, Weiner DB, Paterson Y. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology. 333: 88-101. PMID 15708595 DOI: 10.1016/J.Virol.2004.12.026 |
0.642 |
|
| 2005 |
Hussain SF, Paterson Y. What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors. Cancer Immunology, Immunotherapy : Cii. 54: 577-86. PMID 15650885 DOI: 10.1007/S00262-004-0600-2 |
0.531 |
|
| 2004 |
Sewell DA, Shahabi V, Gunn GR, Pan ZK, Dominiecki ME, Paterson Y. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7. Cancer Research. 64: 8821-5. PMID 15604239 DOI: 10.1158/0008-5472.Can-04-1958 |
0.753 |
|
| 2004 |
Verch T, Pan ZK, Paterson Y. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. Infection and Immunity. 72: 6418-25. PMID 15501772 DOI: 10.1128/Iai.72.11.6418-6425.2004 |
0.429 |
|
| 2004 |
Hussain SF, Paterson Y. CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 339-46. PMID 15314542 DOI: 10.1097/00002371-200409000-00002 |
0.541 |
|
| 2004 |
Paterson Y, Johnson RS. Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens. Expert Review of Vaccines. 3: S119-34. PMID 15285711 DOI: 10.1586/14760584.3.4.S119 |
0.653 |
|
| 2004 |
Neeson P, Paterson Y. A new multi-parameter flow cytometric assay for monitoring lymphoma growth and spread in a pre-clinical murine model for human lymphoma Cytometry Part A. 60: 8-20. PMID 15229853 DOI: 10.1182/Blood.V104.11.4606.4606 |
0.428 |
|
| 2004 |
Peng X, Hussain SF, Paterson Y. The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function. Journal of Immunology (Baltimore, Md. : 1950). 172: 6030-8. PMID 15128786 DOI: 10.4049/Jimmunol.172.10.6030 |
0.405 |
|
| 2004 |
Kwak H, Mustafa W, Speirs K, Abdool AJ, Paterson Y, Isaacs SN. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. Virology. 322: 337-48. PMID 15110531 DOI: 10.1016/J.Virol.2004.02.007 |
0.486 |
|
| 2004 |
Sewell DA, Douven D, Pan ZK, Rodriguez A, Paterson Y. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine. Archives of Otolaryngology--Head & Neck Surgery. 130: 92-7. PMID 14732776 DOI: 10.1001/Archotol.130.1.92 |
0.407 |
|
| 2003 |
Maki PA, Paterson Y, Kennedy AR. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans. Nutrition and Cancer. 22: 185-93. PMID 14502847 DOI: 10.1080/01635589409514343 |
0.34 |
|
| 2003 |
Paterson Y. Rational approaches to immune regulation. Immunologic Research. 27: 451-62. PMID 12857988 DOI: 10.1385/Ir:27:2-3:451 |
0.539 |
|
| 2003 |
Peters C, Peng X, Douven D, Pan ZK, Paterson Y. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag. Journal of Immunology (Baltimore, Md. : 1950). 170: 5176-87. PMID 12734365 DOI: 10.4049/Jimmunol.170.10.5176 |
0.425 |
|
| 2003 |
Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 422: 522-6. PMID 12660734 DOI: 10.1038/Nature01520 |
0.345 |
|
| 2003 |
Salzman NH, Chou MM, de Jong H, Liu L, Porter EM, Paterson Y. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infection and Immunity. 71: 1109-15. PMID 12595421 DOI: 10.1128/Iai.71.3.1109-1115.2003 |
0.323 |
|
| 2003 |
Peters C, Paterson Y. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts. Vaccine. 21: 1187-94. PMID 12559797 DOI: 10.1016/S0264-410X(02)00554-6 |
0.488 |
|
| 2002 |
Matthews AE, Lavi E, Weiss SR, Paterson Y. Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. Journal of Neurovirology. 8: 257-64. PMID 12053280 DOI: 10.1080/13550280290049697 |
0.709 |
|
| 2002 |
Matthews AE, Weiss SR, Paterson Y. Murine hepatitis virus--a model for virus-induced CNS demyelination. Journal of Neurovirology. 8: 76-85. PMID 11935460 DOI: 10.1080/13550280290049534 |
0.695 |
|
| 2001 |
Matthews AE, Weiss SR, Lavi E, Shlomchik M, Paterson Y. The role of B cells in mouse hepatitis virus infection and pathology. Advances in Experimental Medicine and Biology. 494: 363-8. PMID 11774493 DOI: 10.1007/978-1-4615-1325-4_54 |
0.684 |
|
| 2001 |
Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. Journal of Immunology (Baltimore, Md. : 1950). 167: 6471-9. PMID 11714814 DOI: 10.4049/Jimmunol.167.11.6471 |
0.733 |
|
| 2001 |
Matthews AE, Weiss SR, Shlomchik MJ, Hannum LG, Gombold JL, Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. Journal of Immunology (Baltimore, Md. : 1950). 167: 5254-63. PMID 11673540 DOI: 10.4049/Jimmunol.167.9.5254 |
0.718 |
|
| 2001 |
Beatty GL, Paterson Y. Regulation of tumor growth by IFN-γ, in cancer immunotherapy Immunologic Research. 24: 201-210. PMID 11594457 DOI: 10.1385/Ir:24:2:201 |
0.417 |
|
| 2001 |
Lamikanra A, Pan ZK, Isaacs SN, Wu TC, Paterson Y. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8+ T-cell responses that home to the tumor site Journal of Virology. 75: 9654-9664. PMID 11559797 DOI: 10.1128/Jvi.75.20.9654-9664.2001 |
0.519 |
|
| 2001 |
Gunn GR, Peters C, Paterson Y. Listeriolysin--a useful cytolysin. Trends in Microbiology. 9: 161-2. PMID 11357827 DOI: 10.1016/S0966-842X(01)02006-6 |
0.6 |
|
| 2001 |
Gérard CM, Baudson N, Kraemer K, Bruck C, Garçon N, Paterson Y, Pan ZK, Pardoll D. Therapeutic potential of protein and adjuvant vaccinations on tumour growth Vaccine. 19: 2583-2589. PMID 11257396 DOI: 10.1016/S0264-410X(00)00486-2 |
0.399 |
|
| 2001 |
Weiskirch LM, Pan ZK, Paterson Y. The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms Clinical Immunology. 98: 346-357. PMID 11237558 DOI: 10.1006/Clim.2000.4987 |
0.513 |
|
| 2001 |
Mata M, Yao ZJ, Zubair A, Syres K, Paterson Y. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge. Vaccine. 19: 1435-45. PMID 11163666 DOI: 10.1016/S0264-410X(00)00379-0 |
0.446 |
|
| 2001 |
Beatty GL, Paterson Y. IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-γ Journal of Immunology. 166: 2276-2282. PMID 11160282 DOI: 10.4049/Jimmunol.166.4.2276 |
0.438 |
|
| 2000 |
Beatty GL, Paterson Y. IFN-γ can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen Journal of Immunology. 165: 5502-5508. PMID 11067903 DOI: 10.4049/Jimmunol.165.10.5502 |
0.418 |
|
| 1999 |
Pan ZK, Weiskirch LM, Paterson Y. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine Cancer Research. 59: 5264-5269. PMID 10537307 |
0.406 |
|
| 1999 |
Mata M, Paterson Y. Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens Journal of Immunology. 163: 1449-1456. PMID 10415046 |
0.315 |
|
| 1998 |
Mylvaganam SE, Paterson Y, Getzoff ED. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. Journal of Molecular Biology. 281: 301-22. PMID 9698550 DOI: 10.1006/Jmbi.1998.1942 |
0.325 |
|
| 1997 |
Weiskirch LM, Paterson Y. Listeria monocytogenes: A potent vaccine vector for neoplastic and infectious disease Immunological Reviews. 158: 159-169. PMID 9314084 DOI: 10.1111/J.1600-065X.1997.Tb01002.X |
0.486 |
|
| 1997 |
Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y. CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. Journal of Neurovirology. 3: 225-8. PMID 9200070 DOI: 10.3109/13550289709018297 |
0.376 |
|
| 1997 |
Ikonomidis G, Portnoy DA, Gerhard W, Paterson Y. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines Vaccine. 15: 433-440. PMID 9141215 DOI: 10.1016/S0264-410X(96)00188-0 |
0.359 |
|
| 1996 |
Paterson Y, Ikonomidis G. Recombinant Listeria monocytogenes cancer vaccines Current Opinion in Immunology. 8: 664-669. PMID 8902392 DOI: 10.1016/S0952-7915(96)80083-5 |
0.49 |
|
| 1996 |
Paterson Y, Pan ZK, Weiskirch L, Beatty G. The role of cytok1nes in anti-tumor immunity induced by a live recombinant lister1a monocytogenes vaccine Faseb Journal. 10. |
0.383 |
|
| 1995 |
Lavi E, Wang Q, Gombold J, Sutherland R, Paterson Y, Weiss S. Pathology of MHV-A59 infection in beta 2 microglobulin negative mice. Advances in Experimental Medicine and Biology. 380: 179-81. PMID 8830476 DOI: 10.1007/978-1-4615-1899-0_29 |
0.366 |
|
| 1995 |
Sutherland RM, Brassell S, Liu Q, Paterson Y. The self antigen heme evades immune recognition by sequestration in some hemoproteins European Journal of Immunology. 25: 1810-1814. PMID 7621858 DOI: 10.1002/Eji.1830250703 |
0.369 |
|
| 1995 |
Frankel FR, Hegde S, Lieberman J, Paterson Y. Induction of cell-mediated immune responses to human immunodeficiency virus type I gag protein by using Listeria monocytogenes as a live vaccine vector Journal of Immunology. 155: 4775-4782. PMID 7594479 |
0.312 |
|
| 1995 |
Pan ZK, Ikonomidis G, Paterson Y, Pardoll D. Regression of Established Tumors in Mice Mediated by the Oral Administration of a Recombinant Listeria monocytogenes Vaccine Cancer Research. 55: 4776-4779. PMID 7585503 |
0.374 |
|
| 1995 |
Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours Nature Medicine. 1: 471-477. PMID 7585097 DOI: 10.1038/Nm0595-471 |
0.458 |
|
| 1995 |
Gombold JL, Sutherland RM, Lavi E, Paterson Y, Weiss SR. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microbial Pathogenesis. 18: 211-21. PMID 7565015 DOI: 10.1016/S0882-4010(95)90058-6 |
0.364 |
|
| 1995 |
Sutherland RM, Pan ZK, Caton AJ, Tang XX, Cerasoli DM, Paterson Y. T cells from unprimed mice respond to the self antigen heme, in a class II restricted manner, at a frequency similar to alloresponses. International Immunology. 7: 771-83. PMID 7547704 DOI: 10.1093/Intimm/7.5.771 |
0.379 |
|
| 1994 |
Ikonomidis G, Paterson Y, Kos FJ, Portnoy DA. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes Journal of Experimental Medicine. 180: 2209-2218. PMID 7964496 DOI: 10.1084/Jem.180.6.2209 |
0.372 |
|
| 1992 |
Schafer R, Portnoy DA, Brassell SA, Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine Journal of Immunology. 149: 53-59. PMID 1607662 |
0.313 |
|
| 1991 |
Mylvaganam SE, Paterson Y, Kaiser K, Bowdish K, Getzoff ED. Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms Journal of Molecular Biology. 221: 455-462. PMID 1656053 DOI: 10.1016/0022-2836(91)80066-4 |
0.308 |
|
| 1989 |
Collawn JF, Bhayani H, Paterson Y. An analysis of the physical properties of peptides that influence the pigeon cytochrome c specific T lymphocyte response Molecular Immunology. 26: 1069-1079. PMID 2481824 DOI: 10.1016/0161-5890(89)90071-0 |
0.331 |
|
| 1986 |
Jemmerson R, Paterson Y. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes Science. 232: 1001-1004. PMID 2422757 DOI: 10.1126/Science.2422757 |
0.325 |
|
| 1985 |
Tainer JA, Getzoff ED, Paterson Y, Olson AJ, Lerner RA. The atomic mobility component of protein antigenicity Annual Review of Immunology. 3: 501-535. PMID 2415142 DOI: 10.1146/Annurev.Iy.03.040185.002441 |
0.368 |
|
| Show low-probability matches. |